Pendergrass J H, Skjold A C, Cattell J A, Stover L R
Clin Chem. 1986 Jul;32(7):1400-2.
The control system described here is used to monitor the performance of urinary reagent-strip tests for leukocytes. The presence of leukocyte esterase in the urine is used as a marker for leukocytes in urine. The control system is based on sonicated leukocytes, isolated from whole blood. The esterase activity of this sonicate is determined by spectrophotometry with the N-tosyl-L-alanine ester of 5-phenyl-3-hydroxypyrrole as substrate. The assay result is used to determine the amount of sonicate needed to prepare buffered esterase-containing solutions. Such control solutions mimic leukocytic urines and are stable for 6 h at room temperature. The variability of the control system was tested by preparing it five times in a day on five separate days. The overall CV for Leukostix Reagent Strips (Ames Division, Miles Laboratories, Inc.) when tested with these solutions and analyzed with a reflectance spectrophotometer was 8%; for visual readings it was 10%. The overall CV for Chemstrip LN Reagent Strips (Biodynamics, Indianapolis, IN) was 10%.
此处所述的控制系统用于监测尿液试剂条检测白细胞的性能。尿液中白细胞酯酶的存在用作尿液中白细胞的标志物。该控制系统基于从全血中分离出的经超声处理的白细胞。这种超声处理液的酯酶活性通过以5-苯基-3-羟基吡咯的N-甲苯磺酰-L-丙氨酸酯为底物的分光光度法测定。测定结果用于确定制备含缓冲酯酶溶液所需的超声处理液的量。此类对照溶液模拟白细胞尿,在室温下可稳定6小时。通过在五个不同的日子里每天制备五次来测试该控制系统的变异性。用这些溶液进行测试并用反射分光光度计分析时,Leukostix试剂条(米尔斯实验室公司艾姆斯分部)的总体变异系数为8%;目视读数时为10%。Chemstrip LN试剂条(印第安纳州印第安纳波利斯市生物动力学公司)的总体变异系数为10%。